Skip to main content
Clinical Trials/ITMCTR1900002389
ITMCTR1900002389
Not Yet Recruiting
N/A

Multicenter prospective cohort study for the prevention and treatment of hydrocephalus after acute cerebral hemorrhage with traditional Chinese medicine

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Traditional Chinese Medicine Hospital)0 sitesTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Traditional Chinese Medicine Hospital)
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Traditional Chinese Medicine Hospital)

Eligibility Criteria

Inclusion Criteria

  • (1\) The first time onset cerebral hemorrhage;
  • (2\) Meet the diagnostic criteria for cerebral hemorrhage, and the GCS score is \>4 points;
  • (3\) Aged 40 and 75 years old;
  • (4\) Agree to participate in the trial and sign the informed consent form.

Exclusion Criteria

  • (1\) The patient's cerebral hemorrhage is caused by brain tumor, brain trauma, blood disease (secondary to anticoagulant and thrombolytic therapy);
  • (2\) with a mixed stroke or cerebral hemorrhage with severe bleeding needs to surgery;
  • (3\) The clinical manifestations of cerebral palsy, including the disappearance of ipsilateral pupillary reflexes and other third pairs of cranial nerve paralysis;
  • (4\) with pulmonary heart disease, unstable angina or acute myocardial infarction within 6 months;
  • (5\) with neurological deficits (mRS\>2\) before the onset of AICH;
  • (6\) Accompanied by severe cardiac insufficiency (NYHA cardiac function classification III\-IV);
  • (7\) Accompanied by severe hepatic insufficiency (the liver function test results exceed 2 times the upper limit of the normal range);
  • (8\) Accompanied by severe renal insufficiency (the serum creatinine is more than twice the upper limit of the normal range);
  • (9\) Active gastrointestinal bleeding occurs after the onset of AICH in patients;
  • (10\) The patient has a heavier blood system or other systemic underlying disease;

Outcomes

Primary Outcomes

Not specified

Similar Trials